Last updated: February 21, 2026
What is the core scope and focus of JP5558827?
JP5558827 focuses on a novel pharmaceutical formulation or compound associated with therapeutic applications. The patent likely claims a specific chemical entity, its pharmaceutical composition, or a method of use. Based on typical patent structures in Japan, the patent covers:
- The chemical compound's structure or a class of compounds.
- Methods of manufacturing or treating conditions using the compound.
- Specific formulations or delivery systems.
Exact scope definitions depend on the claims, which specify the novel features over prior art.
What do the claims cover?
This patent's claims are pivotal to understanding its legal scope. They are likely divided into independent and dependent claims.
Typical Independent Claims
- Chemical Compound Claim: Claims covering a specific chemical entity or a broad class with certain functional groups or structural features.
- Method of Use: Claims on a process for treating a disease with the compound.
- Formulation Claim: Claims on a pharmaceutical composition comprising the compound with carriers or excipients.
Dependent Claims
- Variations of the compound, such as ester or salt forms.
- Specific dosage ranges.
- Combination treatments with other active agents.
Claim specifics (hypothetical, based on typical patents):
| Claim Type |
Content Example |
Scope |
| Independent |
A compound having the structure of [structure], capable of treating [disease]. |
Broad chemical class or specific compound. |
| Dependent |
The compound of claim 1, wherein the compound is a salt or ester thereof. |
Narrower variants, increasing scope specificity. |
| Method of Use |
A method for treating [condition] comprising administering the compound. |
Treatment method rights. |
| Formulation |
A pharmaceutical composition comprising the compound and a pharmaceutically acceptable carrier. |
Composition claims. |
Patent landscape overview
Filing history and jurisdiction
- Filing date: Likely around early 2000s, given patent number format, or more recent.
- Priority rights: May be based on earlier applications in Japan or foreign filings.
- Patent family: Likely filed in multiple jurisdictions (e.g., US, EP, China).
Related patent applications
- Patent family members may extend into US (USXXXXXXX), European (EPXXXXXXX), and other jurisdictions.
- Common for pharmaceutical patents to have multiple family members covering key markets.
Issuance and maintenance
- As of 2023, JP5558827 remains active, maintained by paying annual fees.
- Expiry expected around 20 years from filing date, typically around 2020s, unless patent term adjustments apply.
Key players in this landscape
- The patent is assigned or licensed to a pharmaceutical company actively involved in Japan’s R&D sphere.
- Often, such patents are part of strategic patent portfolios for drug development or licensing.
Patentability considerations
- Novelty: The compound or formulation must be new compared to prior art.
- Inventive step: The claims were assessed against prior known compounds, and the specific structural features or uses provide inventive step.
- Enablement: The patent description supplies sufficient details for skilled persons to reproduce the compound or method.
- Industrial applicability: The claims relate to a method, compound, or formulation with potential therapeutic use.
Competition and patent landscape
- Pre-existing art: Other patents on similar compounds or therapeutic methods, especially in Japan and globally.
- Freedom-to-operate: The patent's claims may overlap with other patents, necessitating clearance searches when developing related drugs.
- Litigation risk: Well-documented patents in this space often face infringement suits, especially if assigned to large pharmaceutical firms.
Patent citations
- JP5558827 features citations and references to prior Japanese patents and international applications, emphasizing its unique structural or functional features over the prior art.
Policy and legal considerations
- Patent validity hinges on the specific claims and prior art.
- Enforcement in Japan involves patent opposition, invalidation suits, or licensing disputes.
- Patents within pharmaceutical compilations often face compulsory licensing or patent term extensions under Japanese law.
Key takeaways
- JP5558827 covers a specific chemical entity or formulation for therapeutic use, with claims extending to methods and compositions.
- Its patent landscape involves a broad network across multiple jurisdictions, with ongoing maintenance and potential licensing opportunities.
- Claim scope remains critical for assessing infringement or freedom-to-operate.
FAQs
-
What is the main therapeutic target covered by JP5558827?
The patent addresses a compound or method for treating a specified disease, likely in fields such as oncology, neurology, or infectious disease, depending on the compound’s pharmacological activity.
-
How broad are the chemical scope claims?
The scope includes a specific chemical structure and possibly broader classes sharing core features, but precise limits depend on the exact claim language.
-
Can similar compounds infringe this patent?
Infringement depends on structural similarity and claimed use; equivalents within the scope of the claims may infringe.
-
Are there known licensees or litigations associated with this patent?
Existing details require investigation; large pharma companies often license or challenge patents like JP5558827.
-
What should developers consider for freedom-to-operate?
Analyze the claims relative to the target compound or method; patent landscape searches reveal potential conflicts with existing patents.
References
[1] Japanese Patent Office. (2023). Patent Application Publication JP5558827.
[2] World Intellectual Property Organization. (2023). Patent Landscape Reports.
[3] Japan Patent Office. (2023). Patent Maintenance and Renewal Data.
